Sign in

CIK 0001396814

  • Large accelerated filer

Pacira BioSciences, Inc.

Sign in to watch
Ticker
PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
510619477
Phone
+1 650-242-8052
Business address
2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
Former names
Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$217,920
in 1 filing, $218K under 10b5-1 plans

Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RIKER LAUREN −$218K Senior Vice President, Finance sold 9% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-10 CHRISTIE CHRISTOPHER Director Grant or award +6,405 23,059
2026-06-10 CHRISTIE CHRISTOPHER Director Grant or award · Stock Option (Right to Buy) +10,891 10,891
2025-06-11 CHRISTIE CHRISTOPHER Director Grant or award +6,163 16,654
2025-06-11 CHRISTIE CHRISTOPHER Director Grant or award · Stock Option (Right to Buy) +11,279 11,279
2024-06-12 CHRISTIE CHRISTOPHER Director Grant or award +5,230 10,491
2024-06-12 CHRISTIE CHRISTOPHER Director Grant or award · Stock Option (Right to Buy) +12,179 12,179
2023-06-14 CHRISTIE CHRISTOPHER Director Grant or award +1,775 5,261
2023-06-14 CHRISTIE CHRISTOPHER Director Grant or award · Stock Option (Right to Buy) +12,925 12,925
2022-06-08 CHRISTIE CHRISTOPHER Director Grant or award +1,160 3,486
2022-06-08 CHRISTIE CHRISTOPHER Director Grant or award · Stock Option (Right to Buy) +8,225 8,225

Page 1 of 1 · 10 trades